Posted in:Legal AbbVie Loses Battle to Drop Royalties on Blockbuster Humira® By Andrew Storaska February 14, 2018 Comments are off Last week, the Federal Circuit affirmed a lower court’s dismissal of AbbVie’s complaint seeking declaratory judgment of invalidity of... Read more Tagged with: AbbVie, adalimumab, AstraZeneca, Federal Circuit, Humira®, Legal, MedImmune http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus